Showing results (1311-1320 of 1,350) with videos related to
Sort By:
Pageof 135
Drug Development Research|March 27, 2025
Carboxymethyl Starch: A Contemporary Paradigm for Anti Cancer Drug DeliveryRabab FatimaDrug Development Research|March 9, 2026
Exploring Pyrazolo[3,4-b]Pyridine and Spiro-Oxindole Hybrids as Selective CDK2 or EGFR Inhibitors for Targeted Cancer Therapy: Design, Synthesis, and Molecular Modeling InsightsAhmed K B A W Farouk, Aya A A Al-Tanany, Mohamed R Elnagar, et al.Drug Development Research|March 9, 2026
Pyrrolidine Derivatives in Modern Drug Discovery: Emerging Structure Activity Relationships and Dual Antidiabetic-Anticancer PotentialAeyaz Ahmad Bhat, Meraj Ahmed, Noureddine Elboughdiri, et al.Drug Development Research|March 2, 2026
Has AI Reshaped Drug Discovery, or Is There Still a Long Way to Go?Karthik Shree Harini, Devaraj EzhilarasanDrug Development Research|March 9, 2026
Zeylenone Attenuates Tamoxifen Resistance by Directly Binding to CTCF and Inhibiting the CTCF-CENPK-JAK1/STAT3 Signaling Axis in Breast CancerGang Li, Zhiping Deng, Wenqing Zhang, et al.Drug Development Research|March 10, 2026
Structure-Guided Optimization and Biological Validation of 1,3,4-Thiadiazole-Based SIRT2 Inhibitors Reinforcing Channel Entrance InteractionsAhmet Bugra Aksel, Fikriye Ozgencil, Filiz Bakar-Ates, et al.Drug Development Research|February 24, 2024
Network pharmacology analysis and experimental verification of the antitumor effect and molecular mechanism of isocryptomerin on HepG2 cellsJing-Long Cao, Shu-Mei Li, Yan-Jun Tang, et al.Drug Development Research|February 13, 2024
Costunolide attenuates high-fat diet-induced inflammation and oxidative stress in non-alcoholic fatty liver diseaseJiong Wang, Bo Jin, Yanghao Chen, et al.Drug Development Research|February 13, 2024
2-Thioxo-3,4-dihydropyrimidine and thiourea endowed with sulfonamide moieties as dual EGFR<sup>T790M</sup> and VEGFR-2 inhibitors: Design, synthesis, docking, and anticancer evaluationsMohamed S A El-Gaby, Mohamed A M Abdel Reheim, Zuhir S M Akrim, et al.Drug Development Research|February 13, 2024
Tri-substituted 1,3,5-triazine-based analogs as effective HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs): A systematic reviewZebabanu Khalifa, Amit B PatelPageof 135